Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.36 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 2/20 | 0.35 |
| ▸ | ELANE | P08246 | 3/20 | 0.33 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GBA1 | P04062 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | BTN3A1 | O00481 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1640972 | 1.00 | POLB (0.44) | POLBGAANPSR1PRKCAALDH1A1 | |
| SCHEMBL4885829 | 1.00 | POLB (0.44) | POLBGAANPSR1PRKCAALDH1A1 | |
| SCHEMBL5021535 | 1.00 | POLB (0.44) | POLBGAANPSR1PRKCAALDH1A1 | |
| SCHEMBL4258156 | 0.92 | POLB (0.48) | POLBGAANPSR1PRKCAALDH1A1 | |
| SCHEMBL12392875 | 0.91 | POLB (0.40) | POLBGAANPSR1PRKCAALDH1A1 | |
| SCHEMBL408792 | 0.91 | MEN1 (0.48) | POLBGAANPSR1PRKCAALDH1A1 | |
| SCHEMBL16021740 | 0.91 | ALDH1A1 (0.56) | POLBGAANPSR1PRKCAALDH1A1 | |
| SCHEMBL12972548 | 0.91 | POLB (0.40) | POLBGAANPSR1PRKCAALDH1A1 | |
| SCHEMBL13686744 | 0.91 | ALDH1A1 (0.40) | POLBGAANPSR1PRKCAALDH1A1 | |
| SCHEMBL408378 | 0.91 | ALDH1A1 (0.40) | POLBGAANPSR1PRKCAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8404258-B2 | External preparation for the skin | SHISEIDO COMPANY, LTD. (JP) | 2013-03-26 | — | — | US | disclosed |
| US-8404258-B2 | External preparation for the skin | SHISEIDO COMPANY, LTD. (JP) | 2013-03-26 | — | — | US | disclosed |
| US-20080293811-A1 | External preparation for the the skin | SHISEIDO COMPANY, LTD. (JP) | 2008-11-27 | — | — | US | disclosed |
| US-20080293811-A1 | External preparation for the the skin | SHISEIDO COMPANY, LTD. (JP) | 2008-11-27 | — | — | US | disclosed |
| EP-1430905-B1 | SKIN TREATMENT COMPOSITION | SHISEIDO CO LTD (JP) | 2007-11-14 | — | — | EP | disclosed |
| EP-1430905-B1 | SKIN TREATMENT COMPOSITION | SHISEIDO CO LTD (JP) | 2007-11-14 | — | — | EP | disclosed |
| EP-1430905-A4 | EXTERNAL PREPARATION FOR THE SKIN | SHISEIDO CO LTD (JP) | 2006-06-14 | — | — | EP | disclosed |
| US-20040197361-A1 | External preparation for the skin | SHISEIDO COMPANY, LTD. (JP) | 2004-10-07 | — | — | US | disclosed |
| US-20040197361-A1 | External preparation for the skin | SHISEIDO COMPANY, LTD. (JP) | 2004-10-07 | — | — | US | disclosed |
| CN-1535162-A | External preparation for skin | ������������ʽ���� | 2004-10-06 | — | — | CN | disclosed |
| EP-1430905-A1 | EXTERNAL PREPARATION FOR THE SKIN | SHISEIDO COMPANY LIMITED (JP) | 2004-06-23 | — | — | EP | disclosed |
| EP-1430905-A1 | EXTERNAL PREPARATION FOR THE SKIN | SHISEIDO COMPANY LIMITED (JP) | 2004-06-23 | — | — | EP | disclosed |
| WO-2003026698-A1 | EXTERNAL PREPARATION FOR THE SKIN | SHISEIDO COMPANY, LTD. (JP) | 2003-04-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040197361-A1 | External preparation for the skin | CUTA, DDOST, DSG1 | POLB 830/4885GAA 1411/4885NPSR1 935/4885 |
| US-20080293811-A1 | External preparation for the the skin | CUTA, DDOST, DSG1 | POLB 912/4885GAA 1285/4885NPSR1 979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.